| S2633 |
NPS-2143
|
NPS-2143 (SB262470) is a novel potent and selective antagonist of Ca(2+) receptor with IC50 of 43 nM.
|
-
Biomed Pharmacother, 2023, 163:114843
-
Toxins (Basel), 2023, 16(1)21
-
Kaohsiung J Med Sci, 2022, 10.1002/kjm2.12601
|
|
| S1260 |
Cinacalcet (AMG-073) HCl
|
Cinacalcet (Mimpara, Sensipar,AMG-073) HCl represents a new class of compounds for the treatment of hyperparathyroidism.
|
-
Int J Mol Sci, 2022, 23(8)4323
-
Int J Mol Sci, 2020, 21(20)E7617
-
Mol Cell Endocrinol, 2020, 501:110654
|
|
| E0359 |
Evocalcet
|
Evocalcet (KHK7580) is an novel oral calcimimetic agent which acts via allosteric activation of the calcium sensing receptor (CaSR). This compound (0, 20 and 60 nM) dose-dependently increases cytoplasmic [Ca2+] concentrations with an EC50 value of 92.7 nM in hCaR-HEK293 cells.
|
|
|